Medical Affairs Outsourcing Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Medical Affairs Outsourcing Market, By Services

7.1. Medical Affairs Outsourcing Market, by Services Type, 2024-2033
7.1.1. Medical Monitoring
7.1.1.1. Market Revenue and Forecast (2021-2033)
7.1.2. Medical Writing & Publishing
7.1.2.1. Market Revenue and Forecast (2021-2033)
7.1.3. Medical Information
7.1.3.1. Market Revenue and Forecast (2021-2033)
7.1.4. Medical Science Liaisons
7.1.4.1. Market Revenue and Forecast (2021-2033)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 8. Global Medical Affairs Outsourcing Market, By Industry

8.1. Medical Affairs Outsourcing Market, by Industry, 2024-2033
8.1.1. Medical Devices
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Pharmaceutical
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Biopharmaceutical
8.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Medical Affairs Outsourcing Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Services (2021-2033)
9.1.2. Market Revenue and Forecast, by Industry (2021-2033)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Services (2021-2033)
9.1.3.2. Market Revenue and Forecast, by Industry (2021-2033)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Services (2021-2033)
9.1.4.2. Market Revenue and Forecast, by Industry (2021-2033)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Services (2021-2033)
9.2.2. Market Revenue and Forecast, by Industry (2021-2033)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Services (2021-2033)
9.2.3.2. Market Revenue and Forecast, by Industry (2021-2033)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Services (2021-2033)
9.2.4.2. Market Revenue and Forecast, by Industry (2021-2033)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Services (2021-2033)
9.2.5.2. Market Revenue and Forecast, by Industry (2021-2033)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Services (2021-2033)
9.2.6.2. Market Revenue and Forecast, by Industry (2021-2033)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Services (2021-2033)
9.3.2. Market Revenue and Forecast, by Industry (2021-2033)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Services (2021-2033)
9.3.3.2. Market Revenue and Forecast, by Industry (2021-2033)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Services (2021-2033)
9.3.4.2. Market Revenue and Forecast, by Industry (2021-2033)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Services (2021-2033)
9.3.5.2. Market Revenue and Forecast, by Industry (2021-2033)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Services (2021-2033)
9.3.6.2. Market Revenue and Forecast, by Industry (2021-2033)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Services (2021-2033)
9.4.2. Market Revenue and Forecast, by Industry (2021-2033)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Services (2021-2033)
9.4.3.2. Market Revenue and Forecast, by Industry (2021-2033)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Services (2021-2033)
9.4.4.2. Market Revenue and Forecast, by Industry (2021-2033)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Services (2021-2033)
9.4.5.2. Market Revenue and Forecast, by Industry (2021-2033)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Services (2021-2033)
9.4.6.2. Market Revenue and Forecast, by Industry (2021-2033)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Services (2021-2033)
9.5.2. Market Revenue and Forecast, by Industry (2021-2033)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Services (2021-2033)
9.5.3.2. Market Revenue and Forecast, by Industry (2021-2033)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Services (2021-2033)
9.5.4.2. Market Revenue and Forecast, by Industry (2021-2033)

Chapter 10. Company Profiles

10.1. ICON plc
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Wuxi Clinical Development, Inc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Pharmaceutical Product Development, LLC
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Ashfield Healthcare Communications
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Indegene Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. IQVIA Holdings Inc
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. The Medical Affairs Company (TMAC)
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. SGS SA
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Syneos Health Inc
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. ZEINCRO Group
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms